Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PYRIDINE DERIVATIVE AND USE THEREOF IN MEDICINE
Document Type and Number:
WIPO Patent Application WO/2022/127774
Kind Code:
A1
Abstract:
Disclosed are a pyridine derivative and the use thereof in medicine. The pyridine derivative has a good binding effect with LANCL2 protein, and has a significant efficacy on ulcerative colitis.

Inventors:
ZHANG JING (CN)
ZHOU XIBING (CN)
WEI YONGGANG (CN)
SUN YI (CN)
Application Number:
PCT/CN2021/137836
Publication Date:
June 23, 2022
Filing Date:
December 14, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHENGDU BAIYU PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D401/14; A61K31/4184; A61K31/4427; A61K31/497; A61P29/00; C07D487/04; C07D487/10
Domestic Patent References:
WO2016064445A12016-04-28
WO2021127472A12021-06-24
Foreign References:
CN111511904A2020-08-07
US20110275558A12011-11-10
Other References:
ADRIA CARBO, RICHARD D. GANDOUR, RAQUEL HONTECILLAS, NOAH PHILIPSON, AYKUT UREN, JOSEP BASSAGANYA-RIERA: "An N , N -Bis(benzimidazolylpicolinoyl)piperazine (BT-11): A Novel Lanthionine Synthetase C-Like 2-Based Therapeutic for Inflammatory Bowel Disease", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 59, no. 22, 23 November 2016 (2016-11-23), US , pages 10113 - 10126, XP055553688, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.6b00412
Attorney, Agent or Firm:
SINO-CREATIVITY INTELLECTUAL PROPERTY LAW FIRM (CN)
Download PDF: